Ray Iskander is the founder and CEO of Novela Neurotech, which aims to simplify and accelerate the discovery of effective cures for a wide range of neurological conditions.
Novel’s Neureka™ smart medtech platform reduces discovery and development times of next-generation neurological treatments. Applications include opioid addiction, pain relief, epilepsy, and Parkinson’s disease.